Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.

Identifieur interne : 000896 ( Main/Exploration ); précédent : 000895; suivant : 000897

Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.

Auteurs : Emmanuel Novy [France] ; Julien Scala-Bertola [France] ; Claire Roger [France] ; Philippe Guerci [France]

Source :

RBID : pubmed:32315803

Descripteurs français

English descriptors


DOI: 10.1016/j.accpm.2020.04.005
PubMed: 32315803
PubMed Central: PMC7166006


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</title>
<author>
<name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32315803</idno>
<idno type="pmid">32315803</idno>
<idno type="doi">10.1016/j.accpm.2020.04.005</idno>
<idno type="pmc">PMC7166006</idno>
<idno type="wicri:Area/Main/Corpus">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001647</idno>
<idno type="wicri:Area/Main/Curation">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001647</idno>
<idno type="wicri:Area/Main/Exploration">001647</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</title>
<author>
<name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Anaesthesia, critical care & pain medicine</title>
<idno type="eISSN">2352-5568</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged (MeSH)</term>
<term>Anti-Bacterial Agents (adverse effects)</term>
<term>Anti-Bacterial Agents (blood)</term>
<term>Anti-Bacterial Agents (pharmacokinetics)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antibiotic Prophylaxis (adverse effects)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Cefepime (adverse effects)</term>
<term>Cefepime (blood)</term>
<term>Coinfection (prevention & control)</term>
<term>Confusion (chemically induced)</term>
<term>Confusion (etiology)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Critical Illness (therapy)</term>
<term>Cross Infection (prevention & control)</term>
<term>Deep Sedation (MeSH)</term>
<term>Delirium (chemically induced)</term>
<term>Delirium (etiology)</term>
<term>Drug Monitoring (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypnotics and Sedatives (therapeutic use)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Ventilator-Associated (prevention & control)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Respiration, Artificial (adverse effects)</term>
<term>Sepsis (prevention & control)</term>
<term>beta-Lactams (adverse effects)</term>
<term>beta-Lactams (blood)</term>
<term>beta-Lactams (pharmacokinetics)</term>
<term>beta-Lactams (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen (MeSH)</term>
<term>Antibactériens (effets indésirables)</term>
<term>Antibactériens (pharmacocinétique)</term>
<term>Antibactériens (sang)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antibioprophylaxie (effets indésirables)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Co-infection (prévention et contrôle)</term>
<term>Confusion (induit chimiquement)</term>
<term>Confusion (étiologie)</term>
<term>Céfépime (effets indésirables)</term>
<term>Céfépime (sang)</term>
<term>Délire avec confusion (induit chimiquement)</term>
<term>Délire avec confusion (étiologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hypnotiques et sédatifs (usage thérapeutique)</term>
<term>Infection croisée (prévention et contrôle)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Maladie grave (thérapie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie infectieuse sous ventilation assistée (prévention et contrôle)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Sepsie (prévention et contrôle)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance des médicaments (MeSH)</term>
<term>Sédation profonde (MeSH)</term>
<term>Ventilation artificielle (effets indésirables)</term>
<term>bêta-Lactames (effets indésirables)</term>
<term>bêta-Lactames (pharmacocinétique)</term>
<term>bêta-Lactames (sang)</term>
<term>bêta-Lactames (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Cefepime</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Cefepime</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Hypnotics and Sedatives</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Antibiotic Prophylaxis</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Confusion</term>
<term>Delirium</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Antibactériens</term>
<term>Antibioprophylaxie</term>
<term>Céfépime</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Ventilation artificielle</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Confusion</term>
<term>Delirium</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr">
<term>Confusion</term>
<term>Délire avec confusion</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr">
<term>Antibactériens</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Coinfection</term>
<term>Cross Infection</term>
<term>Pneumonia, Ventilator-Associated</term>
<term>Sepsis</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Co-infection</term>
<term>Infection croisée</term>
<term>Pneumopathie infectieuse sous ventilation assistée</term>
<term>Sepsie</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Antibactériens</term>
<term>Céfépime</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Critical Illness</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Maladie grave</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antibactériens</term>
<term>Hypnotiques et sédatifs</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Confusion</term>
<term>Délire avec confusion</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Betacoronavirus</term>
<term>Deep Sedation</term>
<term>Drug Monitoring</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
<term>Surveillance des médicaments</term>
<term>Sédation profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32315803</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>08</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2352-5568</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2020</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>Anaesthesia, critical care & pain medicine</Title>
<ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</ArticleTitle>
<Pagination>
<MedlinePgn>387-388</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2352-5568(20)30071-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2020.04.005</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Novy</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scala-Bertola</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roger</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guerci</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Anaesth Crit Care Pain Med</MedlineTA>
<NlmUniqueID>101652401</NlmUniqueID>
<ISSNLinking>2352-5568</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047090">beta-Lactams</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>807PW4VQE3</RegistryNumber>
<NameOfSubstance UI="D000077723">Cefepime</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000077723" MajorTopicYN="N">Cefepime</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003221" MajorTopicYN="N">Confusion</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054810" MajorTopicYN="N">Deep Sedation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053717" MajorTopicYN="N">Pneumonia, Ventilator-Associated</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047090" MajorTopicYN="N">beta-Lactams</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Therapeutic drug monitoring</Keyword>
<Keyword MajorTopicYN="Y">β lactam</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32315803</ArticleId>
<ArticleId IdType="pii">S2352-5568(20)30071-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.accpm.2020.04.005</ArticleId>
<ArticleId IdType="pmc">PMC7166006</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Grand Est</li>
<li>Languedoc-Roussillon</li>
<li>Lorraine (région)</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement>
<li>Nancy</li>
<li>Nîmes</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Grand Est">
<name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
</region>
<name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000896 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000896 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32315803
   |texte=   Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32315803" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021